Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Latin American Examiner.
Press releases published on June 10, 2025

Ironwood Drilling Upgrades Gold Resource to Indicated from Inferred
ROUYN-NORANDA, Quebec, June 10, 2025 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang …

Global Survey Reveals 81% of Enterprise CX Leaders Plan to Deploy AI in 2025
WASHINGTON, June 10, 2025 (GLOBE NEWSWIRE) -- ibex (NASDAQ: IBEX), a leading global provider of business process outsourcing (BPO) and AI-powered customer engagement technology solutions, today announced the results of a new global survey, conducted by …

GoldHaven Resources Commences Auger Drill Program at the Copeçal Gold Project in Mato Grosso, Brazil
VANCOUVER, British Columbia, June 10, 2025 (GLOBE NEWSWIRE) -- GoldHaven Resources Corp. (“GoldHaven” or the “Company”) (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS) is pleased to announce the commencement of the Auger Drill program at its 100%-owned Copeçal Gold …

Western Uranium & Vanadium Announces CAD $5,000,000 Bought Deal Financing
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES Toronto, Ontario and Nucla, Colorado, June 10, 2025 (GLOBE NEWSWIRE) -- Western Uranium …

Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook’s Personalized Care Trial Program
MALVERN. Pa., June 10, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever and wherever they …

GSAC Engineering Secures Multi-Year Recurring Revenue Contract
MIAMI, June 10, 2025 (GLOBE NEWSWIRE) -- GelStat Corporation ("GelStat" or the "Company") (OTC: GSAC), a development stage company currently focused on the research, development, and marketing of engineered solutions for the industrial security industries, …

Enlivex Therapeutics to Present Clinical Data of Allocetra in Osteoarthritis at EULAR 25 European Congress of Rheumatology
Ness-Ziona, Israel, June 10, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that it will present a poster at the European Alliance of …

Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium
SARASOTA, Fla., June 10, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company developing intranasal therapeutics for brain-related conditions, today announced that Greg Gironda, Head of Business Development, will present …

Day One Appoints Michael Vasconcelles, M.D., as Head of Research and Development
Dr. Michael Vasconcelles brings more than 25 years of extensive oncology research, development and health technology expertise and corporate executive leadership to Day One Dr. Vasconcelles to drive pipeline creation and execution BRISBANE, Calif., June 10 …

Outlook Therapeutics® Announces SMC Recommendation of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD
ISELIN, N.J., June 10, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced the Scottish Medicines …

Ashvattha Therapeutics to Present Phase 2 DME and Wet AMD Data at Clinical Trials at the Summit and MaculArt
Ashvattha will present Phase 2 data on migaldendranib, a subcutaneous therapy for DME and wet AMD, which could offer a more patient-friendly alternative to current injection-based treatments Company is exploring new technology to normalize VEGF expression, …

RenaissThera Achieves Discovery Milestone in Its Oral Obesity Drug Program
BENGALURU, India, June 10, 2025 (GLOBE NEWSWIRE) -- RenaissThera Private Limited (“RenaissThera”), a Bengaluru-based biotechnology company, announced a major milestone in its obesity drug discovery program targeting the glucose-dependent insulinotropic …

Vivex® Biologics, Inc. Appoints Industry Veteran Jon E. Block, Ph.D., as Chief Clinical Officer
MIAMI, June 10, 2025 (GLOBE NEWSWIRE) -- Vivex Biologics, Inc., a leader in developing and delivering innovative allografts, today announced the appointment of Jon E. Block, Ph.D., an industry luminary with more than 40 years of leadership experience in …

Indicium lança AI Data Squads para acelerar migrações complexas para Databricks usando Agentic AI e dbt
NOVA YORK, June 10, 2025 (GLOBE NEWSWIRE) -- A Indicium, líder global em serviços de dados e IA, anunciou hoje o lançamento do AI Data Squads as a Service, um novo modelo de entrega que ajuda empresas a executar migrações complexas, modernizar plataformas …

Indicium Launches AI Data Squads to Accelerate Complex Migrations to Databricks Using Agentic AI and dbt
A new services model that brings structure, scale, and consistent quality to the most complex data modernization initiatives NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Indicium, global leader in data and AI services, today announced the launch of AI Data …

Bitget Anti-Scam Report Shows AI-Related Scams Drive $4.6B in Crypto Losses in 2024
VICTORIA, Seychelles, June 10, 2025 (GLOBE NEWSWIRE) -- Bitget, the leading cryptocurrency exchange and Web3 company, has released its 2025 Anti-Scam Research Report in partnership with blockchain security firms SlowMist and Elliptic. The report reveals …

American Tungsten Corp. Identified Multiple Exploration Targets at Ima Mine & Provides an Update on its Technical Report
Vancouver, BC, June 10, 2025 (GLOBE NEWSWIRE) -- American Tungsten Corp. (CSE:TUNG) (OTCQB:DEMRF) (FSE:RK9) (“American Tungsten” or the “Company”) is pleased to provide an update on its exploration plans and independent technical report (the “Technical …

HPQ, Novacium, and Pragma Industries Sign Agreement for Commercial and Industrial Green Hydrogen Production Using METAGENE™ Technology
MONTREAL and LYON, France, June 10, 2025 (GLOBE NEWSWIRE) -- HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company driving innovation in advanced materials and critical process development, and its French …

HPQ Silicium, Novacium et Pragma Industries concluent un accord de coopération industrielle et commerciale pour la production d’hydrogène vert à l’aide de la technologie METAGENE™
MONTRÉAL et LYON, France, 10 juin 2025 (GLOBE NEWSWIRE) -- HPQ Silicium inc. (« HPQ » ou « la Société ») (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), une entreprise technologique spécialisée dans l’innovation en matériaux avancés et dans la mise au point de …

Quell Therapeutics Achieves Key Milestone in its CAR-Treg Cell Therapy Program for Inflammatory Bowel Disease
Quell Therapeutics Achieves Key Milestone in its CAR-Treg Cell Therapy Program for Inflammatory Bowel Disease AstraZeneca exercises option to license the first candidate from the IBD joint research program for further development and commercialization …